Mitoxantrone

FDA Approved: * April 11, 2006
Pharm Company: * BEDFORD
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Mitoxantrone Overview

Mitoxantrone (INN, BAN, USAN; also known as Mitozantrone in Australia; trade name Novantrone) is an anthracenedione antineoplastic agent. Contents 1 Uses 2 Side effects 3 Mechanism of action 4 See also 5 References 6 External links Uses Mitoxantrone is used to treat certain types of cancer, mostly acute myeloid leukemia. It improves the survival rate of children suffering from acute lymphoblastic leukemia relapse.[1] The combination of mitoxantrone and prednisone is app...

Read more Mitoxantrone Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Mitoxantrone

Recent Mitoxantrone Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Mitoxantrone
  • Injection: 20mg/10ml (2mg/ml), 20mg/10ml(2mg/ml), 25mg/12.5ml (2mg/ml), 2mg/ml, 30mg/15ml (2mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Mitoxantrone: (9 results)

Sorted by National Drug Code
  • 0069-0080 Mitoxantrone Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc.
  • 0703-4680 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc
  • 0703-4685 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc
  • 0703-4686 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc
  • 55390-083 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
  • 55390-084 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
  • 55390-085 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
  • 61703-343 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Hospira Worldwide, Inc.
  • 63323-132 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by App Pharmaceuticals, LLC

Other drugs which contain Mitoxantrone or a similar ingredient: (1 result)